ALPHA TEKNOVA, INC. Capitalized Contract Cost, Impairment Loss
ALPHA TEKNOVA, INC. (TKNO) reported Capitalized Contract Cost, Impairment Loss of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedContractCostImpairmentLoss · last filed 2023-08-11
- ALPHA TEKNOVA, INC. capitalized contract cost, impairment loss for the quarter ending 2023-06-30 was $0.00.
- ALPHA TEKNOVA, INC. capitalized contract cost, impairment loss for the quarter ending 2022-09-30 was $0.00.
| Period end | Capitalized Contract Cost, Impairment Loss 3 month | Capitalized Contract Cost, Impairment Loss 6 month | Capitalized Contract Cost, Impairment Loss 9 month |
|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |